Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J's Tremfya approved, further crowding IL-inhibitor market
J&J's Tremfya approved, further crowding IL-inhibitor market
J&J's Tremfya approved, further crowding IL-inhibitor market
Submitted by
admin
on July 15, 2017 - 11:31am
Source:
BioPharma Dive
News Tags:
JNJ
Tremfya
psoriasis
Interleukin-inhibitors
guselkumab
Headline:
J&J's Tremfya approved, further crowding IL-inhibitor market
Do Not Allow Advertisers to Use My Personal information
